Medtronic plcMDTNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank29
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P29
Within normal range
vs 5Y Ago
-2.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -0.11% |
| 2024 | 1.45% |
| 2023 | -1.82% |
| 2022 | 10.15% |
| 2021 | 6.95% |
| 2020 | 0.04% |
| 2019 | 3.28% |
| 2018 | 2.87% |
| 2017 | -1.39% |
| 2016 | 35.61% |